Original Report

Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010†

  1. Sharon K. Greene1,*,
  2. Lingling Li1,
  3. David K. Shay2,
  4. Alicia M. Fry2,
  5. Grace M. Lee1,3,
  6. Steven J. Jacobsen4,
  7. Roger Baxter5,
  8. Stephanie A. Irving6,‡,
  9. Michael L. Jackson7,
  10. Allison L. Naleway8,
  11. James D. Nordin9,
  12. Komal J. Narwaney10,
  13. Tracy A. Lieu1,11,§

Article first published online: 5 NOV 2012

DOI: 10.1002/pds.3363

Issue

Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety

Volume 22, Issue 4, pages 335–344, April 2013

Additional Information

How to Cite

Greene, S. K., Li, L., Shay, D. K., Fry, A. M., Lee, G. M., Jacobsen, S. J., Baxter, R., Irving, S. A., Jackson, M. L., Naleway, A. L., Nordin, J. D., Narwaney, K. J. and Lieu, T. A. (2013), Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010. Pharmacoepidem. Drug Safe., 22: 335–344. doi: 10.1002/pds.3363

Author Information

  1. 1

    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

  2. 2

    Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

  3. 3

    Division of Infectious Diseases and Department of Laboratory Medicine, Children's Hospital Boston, Boston, Massachusetts, USA

  4. 4

    Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA

  5. 5

    Kaiser Permanente Vaccine Study Center, Oakland, California, USA

  6. 6

    Epidemiology Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA

  7. 7

    Group Health Research Institute, Seattle, Washington, USA

  8. 8

    Kaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA

  9. 9

    HealthPartners Research Foundation, Minneapolis, Minnesota, USA

  10. 10

    Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado, USA

  11. 11

    Division of General Pediatrics, Children's Hospital Boston, Boston, Massachusetts, USA

  1. ‡

    Abt Associates, Atlanta, Georgia, USA

  2. §

    Division of Research, Kaiser Permanente Northern California, Oakland, California, USA

*Correspondence to: S. K. Greene, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Ave., 6th Floor, Boston, MA 02215–3920, USA. E-mail: Sharon_Greene@harvardpilgrim.org

  1. †

    The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Publication History

  1. Issue published online: 1 APR 2013
  2. Article first published online: 5 NOV 2012
  3. Manuscript Accepted: 2 OCT 2012
  4. Manuscript Revised: 27 SEP 2012
  5. Manuscript Received: 18 JUL 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS